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Abstract:   
Objective: To compare the sensitivity and specificity of ELISA-based microneutralization test with 
hemaglutination inhibition test for the evaluation of neutralizing antibody against influenza virus (H1N1). Study 
Design: Nonrandomized Quasi Trail. Study Place and Study Duration: Department of Medicine, Allama Iqbal 
memorial teaching hospital, Sialkot and Nishtar Hospital Multan. January 2018 to May 2019. Material and 
methods: A total of 188 patients were enrolled in our study out of which 101 suffered from influenza type A. 
Serum samples were collected from different staff members during this period. ELISA based 
Microneutralization test was performed in 101 samples and similarly Hemagglutination assay was also 
performed in 101 serum samples. Tests were run twice on two separate days and final result was average of the 
two runs. All the data thus obtained was subjected to statistical analysis. Frequency and percentages were 
calculated for qualitative variables like, gender, sensitivity and specificity, while mean and standard deviation 
was calculated for quantitative variables like, age and BMI. Results: Both the tests were performed on all the 
sera samples. The sensitivity of the Hemagglutination Inhibition Test (HI) was 65.34% and the specificity was 
66.51%. On the contrary, the sensitivity was 87.12% and specificity was 90.80% on the ELISA based 
microneutralization assay (micro NT-ELISA). As the sensitivity and specificity of the micro NT-ELISA is more 
than that of Hemagglutination Inhibition Test, this makes ELISA based microneutralization assay 
superior.Conclusion: ELISA based microneutralization test is much more sensitive and specific as compared to 
the hemaglutination inhibitor assay in terms of detection of neutralizing antibodies against influenza virus 
(H1N1). 
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Introduction: 
Seasonal pandemics and epidemics of influenza result in considerable number of mortalities and morbidities and 
it is regarded as a major health issue in the entire world 1. It can be detected with several types of techniques 2. 
One of the techniques is serological assays which are very important in terms of detecting the influenza virus 3. 
All these techniques are helpful in surveillance, sero-epidemiological studies, development of vaccines and their 
evaluation and also for diagnosis of influenza especially whenever a new strain of influenza virus is suspected 4. 
Particular antibodies against certain viral antigen as humoral immune response, are produced as result of 
infection by the virus or if vaccination of the virus. These antibodies are detectable for duration of about two to 
three weeks after the emergence of the symptoms with the help of serological testing 5. This is helpful in 
confirming the past infection without the use of complete virological work up. Even in the presence of 
undetectable virus, a significant rise in antibody titer in serum i.e. more than 4 times the normal, within the 
duration of acute and convalescent phase is sufficiently enough to make a diagnosis 6. The advantages of 
serological assays like, Hemagglutination inhibition test and ELISA based Microneutralization test, are not only 
that these are diagnostically helpful but also that they provide essential knowledge when use for immunological 
and epidemiological surveys and also in evaluation of immunogenicity of a vaccine 7. 
Most commonly used serological test for quantification of antibodies against influenza virus antigen is 
Hemagglutination inhibition test. This test is rendered as gold standard in multiple settings in influenza 
serological testing and is diagnostic test of choice as well 8. It is also used for the determination of 
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immunogenicity of vaccine and also in seasonal surveys. Two difficulties in performance of this test are that, in 
HI (Hemagglutination inhibition) test, the results are dependent upon the types of RBCs and non specific 
inhibitors are inevitably removed from the serum during this test. Other limitations to its use are that HI cannot 
be used in detection of avian viruses like H5N1 & H3N2 subtypes. To overcome these limitations of HI, 
Microneutralization technique has been developed which helps not only in the detection of functional antibodies 
to influenza viruses and vaccinations and in certain circumstances has proved to be more sensitive as compared 
to HI test. Microneutralization test is performed in multiple ways including Cytopathic effect formation in cell 
cultures, RBCs in order to detect released viral antigen or use of ELISA test along with microneutralization in 
order to detect cells infected with human influenza virus. Studies suggest that ELISA technique is much more 
time consuming, difficult procedure to perform and is most commonly requires the presence of monoclonal 
antibodies in the serum which are usually not present in newly infected patients. Another serological test used 
for the detection of neutralizing antibodies in patients with influenza virus infection is known as colorimetric 
microneutralization assay. 
In ELISA based Microneutralization test, standard serum neutralization test is used while ELISA measures the 
viral load or number of infected cells in the blood. This can be divided into three consecutive steps; TCID (tissue 
culture infectious dose) determination, Microneutralization assay of the virus and ELISA. Results can be 
gathered within two days in this test 9. Many studies have evaluated the antibody response in people infected 
with human influenza virus strain H1N1 with the help of hemagglutination inhibitor assay. There are also some 
studies which shown that in terms of sensitivity and specificity in detecting the neutralizing antibodies in serum 
of the infected people with influenza virus, microneutralization combined with ELISA assay are highly efficient. 
No such study has been performed previously in this region of the world in order to compare the HI test to 
Microneutralization-ELISA test for detection of neutralizing antibodies against influenza virus. In this study 
comparison on the basis of sensitivity and specificity of both tests will be performed so that further 
recommendation can be made on the basis of the superiority of the either test. 
Material and Method: 
This is a simple quasi trail performed in department of medicine in Allama Iqbal memorial teaching hospital, 
Sialkot and Nishtar Hospital Multan. January 2018 to May 2019. A total of 188 patients were enrolled in our 
study out of which 101 suffered from influenza type A. Serum samples were collected from different staff 
members during this period. Ethical approval for this study was obtained by Hospitals Ethics Committee. Sample 
size was calculated from the reference study by Ahmad Tavakoli et al 10. Informed consent was obtained from 
the patients prior to the enrollment into the study. A WHO protocol was followed for performing the methods of 
both HI assay and Microneutralization-ELISA test. All the staff members with positive polymerase chain 
reaction or previous vaccination for influenza were included in this study. Exclusion was made in case of acute 
infection, unwilling patients or if patients had some other fatal co morbidity. In order to remove the non specific 
haemagglutination inhibitors, receptor destroying enzyme was used to treat all the serum samples. Then samples 
were further processed by incubating them overnight at 37C in a water bath. Later on samples were heated at 
56C for thirty minutes to inactivate the receptor destroying enzyme. While performing the microneutralization 
test incubation was skipped. Following equation was used to calculate the final titer of viral neutralization; 
X= [(average A490 of virus control wells) – (average A490 of cell control wells)]/2 + (average A490 of CC 
wells) 
Tests were run twice on two separate days and final result was average of the two runs. All the data thus 
obtained was subjected to statistical analysis. Frequency and percentages were calculated for qualitative 
variables like, gender, sensitivity and specificity, while mean and standard deviation was calculated for 
quantitative variables like, age and BMI.  
Results: 
Serum sample was obtained from 188 patients, of which 101 patients had recently suffered from influenza. Mean 
age of all the patients was 32.29±13.25 years, and body mass index was 24.90±2.94 kg/m2. Table-I 
In HI group, positive results were seen in 66 of the diseased persons and 30 of the healthy persons. Negative 
results were seen in 35 of the diseased persons and 57 of the healthy persons. While in Micro neutralization-
ELISA group positive result was seen in 88 of the diseased persons and negative results were seen in 13 of the 
diseased persons. Similarly among the healthy persons in our study 8 showed positive result and 79 showed 
negative result when microneutralization test was applied to assess the serological response of neutralizing 
antibodies in patients with influenza A (H1N1. 
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Both the tests were performed on all the sera samples. The sensitivity of the Hemagglutination Inhibition Test 
(HI) was 65.34% and the specificity was 66.51%. On the contrary, the sensitivity was 87.12% and specificity 
was 90.80% on the ELISA based microneutralization assay (micro NT-ELISA). As the sensitivity and specificity 
of the micro NT-ELISA is more than that of Hemagglutination Inhibition Test, this makes ELISA based 
microneutralization assay superior. Table-II 
Table-I 
Demographic data 
Variable Group-1 (n=100) 
Age, years (mean ±S.D) 32.29±13.25 
Male, n (%) 112 (59.57) 
BMI, kg/m2(mean ±S.D) 24.90±2.94 
Table-II 
Positive and Negative Results of HI and micro NT-ELISA 
TEST Diseased Healthy Total 
HI Positive 66 30 96 
Negative 35 57 92 
Total 101 87 188 
Micro NT-ELISA Positive 88 8 96 
Negative 13 79 92 
Normal  101 87 188 
Data is mentioned as number. 
Discussion: 
In our study, sensitivity and specificity of both tests was compared by performing the test on 101 serum samples 
gathered from the staff members of the department who were either previously infected or were vaccinated 
against human influenza virus A. the sensitivity and specificity of hemaglutination inhibitor assay was lower as 
compared to the sensitivity and specificity of ELISA based microneutralization test used for the detection of 
neutralizing antibodies against influenza A (H1N1 strain). Specificity of hemaglutination inhibitor assay and 
ELISA based microneutralization test was 66.51% and 90.80% respectively. Similarly sensitivity of HI assay 
and ELISA based microneutralization test was 65.34% and 81.12% respectively. Studies have reported that 
microneutralization test is very specific and sensitive in terms of detection of antibodies especially strain specific 
antibodies 2. Positive neutralization test can be demonstrated as negative infectivity and it illustrates that virus 
specific antibodies are present in the serum sample. 
Cytopathic effect based microneutralization test when compared to ELISA based microneutralization test, 
ELISA based test has the superiority as it is reported to be less variable than the former assay 11, 12. 
Hemagglutination assay is considered as gold standard test for serological diagnosis of influenza virus but it has 
lower sensitivity when detection of antibody against human influenza virus strain H3N2 is required 13. In this 
study, a high rate of correlation between the results of the two tests i.e. ELISA based microneutralization test and 
hemaglutination inhibition assay were comparable and had a high correlation in terms of specificity and 
sensitivity. In a previous study when a comparison between HI assay and ELISA based microneutralization test 
was performed results showed that the later one was more sensitive as compared to the HI assay 13. In previously 
reported studies hemaglutination inhibitor assay was superior to ELISA based microneutralization test in terms 
of detecting the antibody titer. HI assay has proved to be superior for detecting higher numbers of antibody titer 
14 but the results of our study show that even though this notion is true about HI assay, the neutralizing property 
is not significantly reflected by HI assay, therefore making ELISA based neutralization test as highly specific 
and sensitive for detection of neutralizing antibodies against human influenza virus. Previously multiple studies 
have been performed to detect antibodies against different influenza virus strains 15, 16 & 17. 
Conclusion: 
ELISA based microneutralization test is much more sensitive and specific as compared to the hemaglutination 
inhibitor assay in terms of detection of neutralizing antibodies against influenza virus (H1N1). 
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